523 related articles for article (PubMed ID: 28619428)
1. Neuromyelitis optica presenting with horner syndrome: A case report and review of literature.
Uludağ İF; Sarıteke A; Öcek L; Zorlu Y; Şener U; Tokuçoğlu F; Uludağ B
Mult Scler Relat Disord; 2017 May; 14():32-34. PubMed ID: 28619428
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
3. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
Asgari N; Skejø HP; Lillevang ST; Stenager E
Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
[TBL] [Abstract][Full Text] [Related]
4. A case of seropositive Neuromyelitis Optica in a paediatric patient with co-existing acute nephrotic syndrome.
Volkman T; Hemingway C
Mult Scler Relat Disord; 2017 Nov; 18():103-105. PubMed ID: 29141789
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
Drori T; Chapman J
Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
7. Recurrent spinal cord attacks in a patient with a limited form of neuromyelitis optica.
Matsumoto H; Shimizu T; Okabe S; Konoma Y; Takahashi T; Hirakawa-Yamada M; Igeta Y; Hashida H
Intern Med; 2011; 50(5):509-13. PubMed ID: 21372469
[TBL] [Abstract][Full Text] [Related]
8. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
9. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
11. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis Optica-AQP4: an update.
Benavente E; Paira S
Curr Rheumatol Rep; 2011 Dec; 13(6):496-505. PubMed ID: 21922173
[TBL] [Abstract][Full Text] [Related]
14. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
15. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
Popescu BF; Guo Y; Jentoft ME; Parisi JE; Lennon VA; Pittock SJ; Weinshenker BG; Wingerchuk DM; Giannini C; Metz I; Brück W; Shuster EA; Carter J; Boyd CD; Clardy SL; Cohen BA; Lucchinetti CF
Neurology; 2015 Jan; 84(2):148-58. PubMed ID: 25503621
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
[TBL] [Abstract][Full Text] [Related]
18. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
[TBL] [Abstract][Full Text] [Related]
20. NMO-IgG: a specific biomarker for neuromyelitis optica.
Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
